4543 Stock Overview
Engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 4543 from our risk checks.
Terumo Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥2,723.50 |
| 52 Week High | JP¥3,014.50 |
| 52 Week Low | JP¥1,856.00 |
| Beta | 0.50 |
| 1 Month Change | 7.29% |
| 3 Month Change | -3.30% |
| 1 Year Change | 31.13% |
| 3 Year Change | 32.08% |
| 5 Year Change | 73.53% |
| Change since IPO | 2,193.47% |
Recent News & Updates
Calculating The Fair Value Of Terumo Corporation (TSE:4543)
May 12
Investors Still Waiting For A Pull Back In Terumo Corporation (TSE:4543)
Apr 12Shareholder Returns
| 4543 | JP Medical Equipment | JP Market | |
|---|---|---|---|
| 7D | 3.7% | 4.4% | 0.4% |
| 1Y | 31.1% | 10.9% | 24.2% |
Return vs Industry: 4543 exceeded the JP Medical Equipment industry which returned 10.9% over the past year.
Return vs Market: 4543 exceeded the JP Market which returned 24.2% over the past year.
Price Volatility
| 4543 volatility | |
|---|---|
| 4543 Average Weekly Movement | 3.5% |
| Medical Equipment Industry Average Movement | 3.7% |
| Market Average Movement | 4.1% |
| 10% most volatile stocks in JP Market | 8.0% |
| 10% least volatile stocks in JP Market | 2.2% |
Stable Share Price: 4543 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4543's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1921 | 30,207 | Hikaru Samejima | www.terumo.com |
Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular and stent grafts.
Terumo Corporation Fundamentals Summary
| 4543 fundamental statistics | |
|---|---|
| Market cap | JP¥4.04t |
| Earnings (TTM) | JP¥106.37b |
| Revenue (TTM) | JP¥921.86b |
38.0x
P/E Ratio4.4x
P/S RatioIs 4543 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4543 income statement (TTM) | |
|---|---|
| Revenue | JP¥921.86b |
| Cost of Revenue | JP¥440.83b |
| Gross Profit | JP¥481.04b |
| Other Expenses | JP¥374.66b |
| Earnings | JP¥106.37b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 71.64 |
| Gross Margin | 52.18% |
| Net Profit Margin | 11.54% |
| Debt/Equity Ratio | 17.5% |
How did 4543 perform over the long term?
See historical performance and comparison